Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Universidade do Porto | OTHER |
Not provided
Not provided
Not provided
Not provided
This is a prospective study involving patients undergoing open renal transplant. Renal transplant recipients were randomly divided into two groups: the NPWT group, which received NPWT, and the Standard group, which received standard wound dressings.
This is a prospective study involving patients undergoing open renal transplant between January 2023 and August 2024. Pediatric patients, those requiring surgical reinterventions within the first 3 postoperative months, and patients allergic to NPWT components were excluded from the study. Renal transplant recipients were randomly divided into two groups: the NPWT group, which received NPWT, and the Standard group, which received standard wound dressings. NPWT (PICO by Smith & Nephew) was applied intraoperatively at 80 mmHg and maintained for 7 days. Wound evaluations were performed at 7, 14, 30, and 90 days post-operatively. If dehiscence was present, it was classified as either deep or superficial based on the involvement of the aponeurosis. Patients were assessed for wound infection using the ASEPSIS score, pain with a visual analogue scale, and quality of life using the EQ-5D questionnaire. Scar healing was also evaluated at 30 and 90 days post-operatively with the POSAS score
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| NPWT group | Active Comparator | Patients who received negative pressure wound therapy |
|
| Standard group | No Intervention | Patients who received standard dressing |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NWPT group | Device | Patients submitted to negative pressure wound therapy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Wound dehiscence | Wound dehiscence - superficial or deep | First 90 days after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Wound infection | ASEPSIS score - (Additional treatment, Serous discharge, Erythema, Purulen exudates, Separation of deep tissues, Isolation of bacteria, Stay in hospital score); 0-10 points; higher score = worse outcome | First 90 days after surgery |
| Pain associated with incision |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Alberto Silva, MD | Contact | +351225512100 | u016845@chsj.min-saude.pt |
| Name | Affiliation | Role |
|---|---|---|
| João Alturas Silva, PhD | São João University Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| São João University Hospital | Recruiting | Porto | Portugal |
IPD will be shared upon reasonable request after consideration from local Ethics Comission
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jul 10, 2025 | Jul 10, 2025 | Prot_SAP_000.pdf |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Visual analogue scale; score 0-10; higher score=worse outcome |
| First 90 days after surgery |
| Quality of life associated with incision | EQ-5D questionnaire (The 5-level quality of life version 5); score 0 -100 ; highest score=better outcome | First 90 days after surgery |
| Scar healing | POSAS score (The Patient and Observer Scar Assessment Scale); score 1-10; highest score=worse outcome | First 90 days after surgery |